ANAB AnaptysBio, Inc. gains 59% Nov 16, 2020

N/Ahttp://www.priceseries.com/trade/ANAB-AnaptysBio-Inc-stock-gains-59-percent-a-Trade-Record-by-priceSeries-2020101320201116.html

IMGN ImmunoGen, Inc. gains 48% Nov 11, 2020

ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha for the treatment of platinum-resistant ovarian cancer; IMGN529, an ADC that is in Phase 1b/2 clinical trials for B-cell malignancies; coltuximab ravtansine, which is in Phase 2 trials for B-cell malignancies; IMGN779 that is in Phase 1 clinical trials for the treatment of acute myeloid leukemia (AML); and IMGN632, a preclinical CD123-targeting ADC for the treatment of hematological malignancies, including AML. ImmunoGen, Inc. has collaborations with Roche; Bayer HealthCare AG; Sanofi; Biotest AG; Novartis Institutes for BioMedical Research, Inc.; Eli Lilly and Company; Amgen; Takeda Pharmaceutical Company Limited; Merck; and CytomX Therapeutics, Inc. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.http://www.priceseries.com/trade/IMGN-ImmunoGen-Inc-stock-gains-48-percent-a-Trade-Record-by-priceSeries-2020100220201111.html

ALGN Align Technology, Inc. gains 38% Nov 11, 2020

Align Technology, Inc. designs, manufactures, and markets a system of clear aligner therapy, intra-oral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services. The company's Clear Aligner segment offers Invisalign Full, a treatment used for a range of malocclusion; Invisalign Teen treatment that addresses orthodontic needs of teenage patients, such as compliance indicators, compensation for tooth eruption, and six free single arch replacement aligners; and Invisalign Assist treatment for anterior alignment and aesthetically-oriented cases. It also provides Invisalign Express (10 and 5) and Invisalign Lite/i7 treatments for orthodontic cases, non-comprehensive treatment relapse cases, or straightening prior to restorative or cosmetic treatments; Invisalign Go, a solution for general practitioner dentists (GPs) to identify and treat patients with mild malocclusion; SmileDirectClub aligners for minor tooth movement; custom clear aligner retainers used to maintain tooth position and correct minor relapse; and SmartTrack, a custom-engineered material that delivers force for orthodontic tooth movements. The company's Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; and Restorative software for iTero, a software for GPs, prosthodontists, periodontists, and oral surgeons. It also provides Orthodontic software for iTero, a software for orthodontists for digital records storage, orthodontic diagnosis, Invisalign digital impression submission, and for the fabrication of printed models and retainers; CAD/CAM services, such as iTero Models and Dies, OrthoCAD iCast, and OrthoCAD iRecord; and Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner, as well as third party scanners and digital scans for Invisalign treatment submission. The company was founded in 1997 and is headquartered in San Jose, California.http://www.priceseries.com/trade/ALGN-Align-Technology-Inc-stock-gains-38-percent-a-Trade-Record-by-priceSeries-2020102020201111.html

PRSC The Providence Service Corp. gains 37% Nov 10, 2020

The Providence Service Corporation, through its subsidiaries, provides critical healthcare and workforce development services for public and private sector entities in the United States and internationally. It operates through two segments, Non-Emergency Transportation Services (NET Services) and Workforce Development Services (WD Services). The NET Services segment offers non-emergency medical transportation services for Medicaid or Medicare eligible members, whose limited mobility or financial resources hinder their ability to access necessary healthcare and social services. The WD Services segment offers workforce development and offender rehabilitation services, including employment preparation and placement, apprenticeship and training, youth community service programs, and other health related services to clients on behalf of governmental and private entities. This segment serves unemployed, disabled, and individuals seeking new skills, as well as individuals that are coping with medical illnesses, newly graduated from educational institutions, and those that have been released from incarceration. The company was founded in 1996 and is headquartered in Stamford, Connecticut.http://www.priceseries.com/trade/PRSC-The-Providence-Service-Corp-stock-gains-37-percent-a-Trade-Record-by-priceSeries-2020092820201110.html

TTS Tile Shop Hldgs, Inc. gains 36% Nov 5, 2020

Tile Shop Holdings, Inc. operates as a specialty retailer of manufactured and natural stone tiles, setting and maintenance materials, and related accessories in the United States. It offers approximately 4,000 products, including ceramic, porcelain, glass, cement, wood look, and metal tiles; and marble, granite, quartz, sandstone, travertine, slate, and onyx tiles primarily under the Rush River and Fired Earth brand names. The company also manufactures setting and maintenance materials, such as thinset, grout, and sealers under the Superior brand name. As of February 24, 2017, it operated 124 stores in 31 states with an average size of 21,200 square feet. The company also sells its products through its Website, tileshop.com. Tile Shop Holdings, Inc. was founded in 1985 and is headquartered in Plymouth, Minnesota.http://www.priceseries.com/trade/TTS-Tile-Shop-Hldgs-Inc-stock-gains-36-percent-a-Trade-Record-by-priceSeries-2020100920201105.html

SELB Selecta Biosciences Inc gains 17% Nov 6, 2020

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company using its proprietary synthetic vaccine particle technology to discover & develop targeted therapies designed to modulate the immune system to treat rare and serious diseases.http://www.priceseries.com/trade/SELB-Selecta-Biosciences-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2020102120201106.html

PNM PNM Resources, Inc. (Holding Co.) gains 18% Nov 6, 2020

PNM Resources, Inc., through its subsidiaries, engages in the energy and energy-related businesses in the United States. It operates through Public Service Company of New Mexico (PNM) and Texas-New Mexico Power Company (TNMP) segments. The PNM segment is primarily involved in the generation, transmission, and distribution of electricity. It generates electricity using coal, natural gas and oil, nuclear fuel, solar, wind, and geothermal energy sources. As of December 31, 2016, this segment had owned or leased facilities with a total net generation capacity of 2,481 megawatts; and owned 3,200 circuit miles of electric transmission lines, 6,060 miles of distribution overhead lines, 5,789 cable miles of underground distribution lines, and 269 substations. The TNMP segment provides regulated transmission and distribution services. As of December 31, 2016, this segment owned 978 circuit miles of overhead electric transmission lines, 7,111 pole miles of overhead distribution lines, 1,209 circuit miles of underground distribution lines, and 115 substations. The company serves approximately 767,000 residential, commercial, and industrial customers, as well as end-users of electricity in New Mexico and Texas. PNM Resources, Inc. was founded in 1917 and is headquartered in Albuquerque, New Mexico.http://www.priceseries.com/trade/PNM-PNM-Resources-Inc-Holding-Co-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2020100120201106.html

NVUS Novus Therapeutics, Inc. gains 21% Nov 6, 2020

Tokai Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for prostate cancer and other hormonally-driven diseases. Its lead drug candidate is galeterone, an oral small molecule that is in various clinical trials for the treatment of patients with metastatic castration-resistant prostate cancer. The company's androgen receptor degradation agents drug discovery program is focused on identifying and developing compounds for patients with androgen receptor signaling diseases, including prostate cancer. Tokai Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Boston, Massachusetts.http://www.priceseries.com/trade/NVUS-Novus-Therapeutics-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2020102820201106.html

COWN Cowen Group, Inc. gains 29% Nov 6, 2020

Cowen Group, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides alternative investment management, investment banking, research, and sales and trading services for its clients. It manages separate client focused portfolio through its subsidiaries. Through its subsidiaries, the firm invests in equity and fixed income markets. It also invests in alternative investments markets through its subsidiaries. Cowen Group, Inc. was founded in 1994 and is headquartered in New York, New York with additional offices in Boston, Massachusetts, Chicago, Illinois, Cleveland, Ohio, Dallas, Texas, and San Francisco, California.http://www.priceseries.com/trade/COWN-Cowen-Group-Inc-stock-gains-29-percent-a-Trade-Record-by-priceSeries-2020093020201106.html

AVXL Anavex Life Sciences Corp. gains 17% Nov 6, 2020

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of Alzheimer's disease, other central nervous system diseases, pain, and various cancers. The company's lead drug candidates include ANAVEX 2-73, a Phase 2a clinical trial for the treatment of Alzheimer's disease; and preclinical stage to treat Parkinson's disease. Its preclinical drug candidates include ANAVEX 3-71, which uses ligands that activate sigma-1 and M1 muscarinic receptors to treat Alzheimer's disease; ANAVEX 1-41, a sigma-1 agonist that protects nerve cells from degeneration or death; ANAVEX 1037 for the treatment of prostate cancer; and ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the treatment of neuropathic and visceral pain. The company was founded in 2006 and is based in New York, New York.http://www.priceseries.com/trade/AVXL-Anavex-Life-Sciences-Corp-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2020101620201106.html